Lineage Looking to Restore Sight, Hearing, Movement – San Diego Business Journal

CARLSBAD – After demonstrating early clinical success in its OpRegen ophthalmology program, Lineage Cell Therapeutics (NYSE: LCTX) has set its …

Do you trust this headline?

Based on recent headline ratings, 97% of this readership currently trusts the local media, which has an average score of 82% regionally and is currently trending positive.

97%

Media Trust Score97%